Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 6/20 | 0.42 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | CTSL | P07711 | 3/20 | 0.35 |
| ▸ | CTSB | P07858 | 3/20 | 0.35 |
| ▸ | CTSH | P09668 | 2/20 | 0.35 |
| ▸ | LTA4H | P09960 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | METAP2 | P50579 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Levopropylhexedrine SCHEMBL20780004 | 1.00 | CTSK (0.42) | CTSKSIGMAR1MEN1KMT2ACTSL | |
| Levopropylhexedrine SCHEMBL161851 | 1.00 | CTSK (0.42) | CTSKSIGMAR1MEN1KMT2ACTSL | |
| Propylhexedrine SCHEMBL28890426 | 0.98 | CTSK (0.41) | CTSKSIGMAR1MEN1KMT2ACTSL | |
| Propylhexedrine SCHEMBL4900116 | 0.98 | CTSK (0.41) | CTSKSIGMAR1MEN1KMT2ACTSL | |
| Cyclopentamine SCHEMBL13479599 | 0.98 | CTSK (0.40) | CTSKSIGMAR1MEN1KMT2ACTSL | |
| Cyclopentamine SCHEMBL249708 | 0.98 | CTSK (0.40) | CTSKSIGMAR1MEN1KMT2ACTSL | |
| Cyclopentamine SCHEMBL317336 | 0.95 | CTSK (0.39) | CTSKSIGMAR1MEN1KMT2ACTSL | |
| SCHEMBL27308544 | 0.93 | — | — | |
| SCHEMBL22627190 | 0.81 | CTSK (0.32) | CTSK | |
| SCHEMBL23241391 | 0.79 | OPRK1 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 8422 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4722714-A1 | SIMULTANEOUS ANALYSIS OF FOOD-BORNE DOPING SUBSTANCES USING LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY (VFD: VACCINE FOR FOODBORNE DOPING) | Korea Institute of Science and Technology (KR) | 2026-04-08 | — | — | EP | claimed |
| EP-4704839-A2 | IMIDAZOLE CONTAINING COMPOUNDS, DERIVATIVES THEREFORE, AND USES THEREOF | ALPHERABIO LLC (US) | 2026-03-11 | — | — | EP | claimed |
| US-20260060949-A1 | METHOD FOR TREATING DAMAGE INDUCED BY SLEEP DEPRIVATION | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2026-03-05 | — | — | US | claimed |
| US-20260027139-A1 | TREATMENT OF SLEEP APNEA WITH A COMBINATION OF A CARBONIC ANHYDRASE INHIBITOR AND AN ALDOSTERONE ANTAGONIST | VIVUS, INC. | 2026-01-29 | — | — | US | claimed |
| WO-2025111482-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS | BEXSON BIOMEDICAL, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| US-20250161525-A1 | Pectin-Carboxymethylcellulose Mesothelial Sealants and Protectants | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. | 2025-05-22 | — | — | US | claimed |
| US-12186447-B2 | Pectin-carboxymethylcellulose mesothelial sealants and protectants | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2025-01-07 | — | — | US | claimed |
| CN-119233997-A | Tetrahedral antibodies | 生物分子控股有限责任公司 | 2024-12-31 | — | — | CN | claimed |
| EP-4463485-A2 | TETRAHEDRAL ANTIBODIES | Biomolecular Holdings LLC (US) | 2024-11-20 | — | — | EP | claimed |
| WO-2024226608-A2 | IMIDAZOLE CONTAINING COMPOUNDS, DERIVATIVES THEREFORE, AND USES THEREOF | AGLAEAPHARMA INC. (US) | 2024-10-31 | — | — | WO | claimed |
| US-5466466-A | Therapeutic system for the retarded and controlled transdermal or transmucous administration of active substrates II | LTS LOHMANN THERAPIE-SYSTEME GMBH & CO. KG (DE) | 1995-11-14 | — | — | US | claimed |
| US-5409944-A | Enzyme inhibitors, antiinflammatory agent, antiseptic agent | MERCK FROSST CANADA, INC. (CA) | 1995-04-25 | — | — | US | claimed |
| WO-1994026731-A1 | 2-SUBSTITUTED-3,4-DIARYLTHIOPHENE DERIVATIVES AS INHIBITORS OF CYCLOOXYGENASE | MERCK FROSST CANADA INC. (CA) | 1994-11-24 | — | — | WO | claimed |
| WO-1994020480-A1 | ALKANESULFONAMIDO-1-INDANONE DERIVATIVES AS INHIBITORS OF CYCLOOXYGENASE | MERCK FROSST CANADA INC. (CA) | 1994-09-15 | — | — | WO | claimed |
| EP-0384266-B1 | Therapeutic system for the sustained and controlled transdermal or transmucosal delivery of active agents | LOHMANN THERAPIE SYST LTS (DE) | 1994-07-20 | — | — | EP | claimed |
| EP-0577757-A4 | — | — | 1994-02-23 | — | — | EP | claimed |
| EP-0577757-A1 | IBUPROFEN-DECONGESTANT COMBINATIONS | MERCK & CO. INC. (US) | 1994-01-12 | — | — | EP | claimed |
| US-5215751-A | THERAPEUTIC SYSTEM FOR THE RETARDED AND CONTROLLED TRANSDERMAL OR TRANSMUCOUS ADMINISTRATION OF ACTIVE SUBSTANCES (I) | LTS LOHMANN THERAPIE SYSTEME GMBH & CO. (DE) | 1993-06-01 | — | — | US | claimed |
| EP-0384267-B1 | THERAPEUTIC SYSTEM FOR THE SUSTAINED AND CONTROLLED TRANSDERMAL OR TRANSMUCOSAL DELIVERY OF ACTIVE AGENTS | LTS Lohmann Therapie-Systeme GmbH & Co. KG (DE) | 1993-05-26 | — | — | EP | claimed |
| WO-1992017171-A1 | IBUPROFEN-DECONGESTANT COMBINATIONS | MERCK & CO., INC. (US) | 1992-10-15 | — | — | WO | claimed |